First Quarter 2015 Highlights

• Revenues of $20.4 million, exceeding guidance by 17%.
• Adjusted earnings* of $ 6.8 million, or 6 cents per basic share, exceeding the high end of guidance by 112%.
• Signed eight licenses including two licenses with Texas Instruments, a license with Covidien related to medical stent technology and two wireless license renewals.
• Acquired a patent portfolio from a major global semiconductor company related to semiconductor power management.
• Returned $5.2 million to shareholders in dividend payments.